Angion
Dr Goldberg founded Angion in 1998 and served as Chairman of the Board, President, and CEO from 1998-2018. Prior to Angion, Dr. Goldberg was a faculty member at Harvard Medical School, Boston, MA, Radiation Oncologist-in-Chief for the North Shore-LIJ (Northwell) Health System, NY, and Professor at the Albert Einstein College of Medicine, Bronx, NY. Dr. Goldberg has made seminal contributions in the field of tyrosine kinase receptors and hepatocyte growth factor research and has been the driving force within Angion since he started the company. Under Dr. Goldberg’s leadership, Angion received continuous non-dilutive NIH, DOD, and NSF grants and successfully raised Series A/B funding.
This person is not in the org chart
This person is not in any offices
Angion
Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.